Study: OTC stomach meds trigger upset

Share this article:

Consumers are paying attention to OTC side effects. A study by research firm Mintel indicates that 38% of consumers with gastrointestinal issues are worried about the impact some of these medications can have on health.

The firm noted that while antacid and laxative sales dropped 2.5% between 2011 and 2013, 29% of stomach-centric shoppers say they have been adopting strategies such as eating more yogurt and fiber-rich foods to limit symptoms.

Mintel said its research does not mean OTC stomach remedy sales are destined to idle. Mintel health and wellness analyst Emily Krol said in a statement that brands can meet consumer concerns through strategies that position their products “as part of an overall healthy lifestyle.”

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.